Drug Class
|
DRM
|
HIV-1 Subtype
|
p value
|
p value
|
p value
|
---|
All
|
A
|
C
|
B
|
G/AG
|
Other
|
A vs. C
|
B vs. C
|
A vs. B
|
---|
N = 337
|
N = 130
|
N = 141
|
N = 34
|
N = 23
|
N = 9
| | | |
---|
PI, n (%)
|
D30N
|
1 (0.3)
| |
1 (0.7)
| | | | | | |
M46I
|
5 (1.5)
|
1 (0.8)
|
4 (2.8)
| | | |
0.222
| | |
V82MS
|
1 (0.3)
| | | |
1 (1.5)
| | | | |
NRTI, n (%)
|
M41L
|
1 (0.3)
| |
1 (0.7)
| | | | | | |
A62V
|
19 (5.6)
|
17 (13)
|
2 (1.4)
| | | |
< 0.001
| | |
D67EGN
|
5 (1.5)
|
3 (2.3)
|
2 (1.4)
| | | |
0.582
| | |
K70R
|
3 (0.9)
|
2 (1.5)
|
1 (0.7)
| | | |
0.526
| | |
M184V
|
5 (1.5)
|
3 (2.3)
|
2 (1.4)
| | | |
0.582
| | |
T215EIS
|
4 (1.2)
|
1 (0.8)
|
3 (2.1)
| | | |
0.376
| | |
K219Q
|
1 (0.3)
|
1 (0.8)
| | | | | | | |
NNRTI, n (%)
|
K101E
|
1 (0.3)
| |
1 (0.7)
| | | | | | |
K103NS
|
14 (4.2)
|
5 (3.8)
|
3 (2.1)
|
4 (11.8)
|
2 (8.7)
| |
0.407
|
0.010
|
0.068
|
V106M
|
1 (0.3)
| |
1 (0.7)
| | | | | | |
E138AGKQ
|
19 (5.6)
|
11 (8.5)
|
6 (4.3)
|
1 (3)
|
1 (4.3)
| |
0.156
|
0.731
|
0.276
|
Y181C
|
5 (1.5)
|
1 (0.8)
|
4 (2.8)
| | | |
0.222
| | |
Y188L
|
1 (0.3)
|
1 (0.8)
| | | | | | | |
G190AS
|
6 (1.8)
|
2 (1.5)
|
4 (2.8)
| | | |
0.465
| | |
- Data are presented as n (%). Differences in proportions were measured using the chi-squared test. Empty cells, n = zero.